Maddalena Castellani Pastoris
Istituto Superiore di Sanità
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Maddalena Castellani Pastoris.
Journal of Immunology | 2004
Giovanna Schiavoni; Claudia Mauri; Davide Carlei; Filippo Belardelli; Maddalena Castellani Pastoris; Enrico Proietti
Legionella pneumophila is an intracellular pathogen whose replication in macrophages is mainly controlled by IFN-γ. Freshly isolated peritoneal macrophages elicited in vivo with thioglycolate (TG) from A/J mice are highly permissive to L. pneumophila growth in vitro, while TG-elicited macrophages from CD1 mice are resistant. In this study, we show that when CD1 TG-macrophages are cultured for 7 days, they become permissive to Legionella infection. We demonstrate that treatment with type I IFN (IFN-αβ) totally inhibits the growth of L. pneumophila in both freshly isolated A/J and in vitro-aged CD1 TG-macrophages. IFN-αβ protective effect on permissive macrophages was comparable to that induced by IFN-γ. Even low doses of either IFN-α or IFN-β alone were effective in inhibiting L. pneumophila multiplication in macrophage cultures. Notably, treatment of resistant, freshly isolated CD1 TG-macrophages with Ab to mouse IFN-αβ significantly enhanced their susceptibility to Legionella infection in vitro, thus implying a role of endogenous IFN-αβ in mediating the natural resistance of macrophages to L. pneumophila infection. Finally, addition of anti-IFN-γ-neutralizing Ab did not restore Legionella growth in IFN-α- or IFN-β-treated A/J or CD1 permissive macrophages, indicating that IFN-αβ effect was not mediated by IFN-γ. This observation was further confirmed by the finding that IFN-αβ was effective in inhibiting L. pneumophila replication in macrophages from IFN-γ receptor-deficient mice. Taken together, our results provide the first evidence for a role of IFN-αβ in the control of L. pneumophila infection in mouse models of susceptible macrophages and suggest the existence of different pathways for the control of intracellular bacteria in macrophages.
Scandinavian Journal of Infectious Diseases | 1988
Maddalena Castellani Pastoris; Egidio F. Viganò; Carla Passi
Three members of one single family of 4, the father, a son and a daughter, showed seroconversion against Legionella pneumophila serogroup 1 (Lp SG1). The son had a severe pneumonia, whereas the father and the daughter did not develop any other illness than mild and transient fever. A fourth member, the mother, remained seronegative. Lp SG1 was detected by a direct immunofluorescence test in water samples from the shower at home, in tap water in the familys butcher shop, and in condensation water from the ventilator of refrigerator cells in the shop. Two different sources of infection appear to have occurred: showering at home and an aerosol of contaminated condensation water. Reports of more than one case of legionella infection within a family seem to be extremely rare and have not been found in the literature.
Italian Journal of Public Health | 2007
Maria Teresa Montagna; Maria Luisa Ricci; Christian Napoli; Daniela Tat; Maria Scaturro; Giovanna Barbuti; Giuseppe Pierucci; Maddalena Castellani Pastoris
Legionella pneumophila is a pathogen that causes severe pneumonia in humans; L. pneumophila serogroup 1 accounts for at least 90% of infections. This is not linked to an environmental predominance of Legionella pneumophila 1, but may be due to a greater virulence of the strain. L. pneumophila sg 5 has also been reported, albeit less frequently, to be a cause of the disease. We report a case of L. pneumophila sg 5 occurring in a large hospital in southern Italy (Apulia region), where both L. pneumophila sg 1 and sg 5 were detected in the water supply; the nosocomial origin was demonstrated by molecular subtyping (PFGE). An environmental investigation, performed immediately after diagnosis of the case of legionellosis, identified a ow L. pneumophila sg 5 contamination level. Our experience highlights that in hospital, risk assessment, in rder to institute control measures for Legionella, should be carried out not only in response to a case of the disease and/or in risk wards only, as described in the Italian Guidelines, but periodically in every ward. The present study confirms that, although in the community L. pneumophila sg 1 is the most frequent strain isolated in both outbreaks and isolated cases, in hospital other serogroups and species may often cause infection because of the high susceptibility of the hosts.
Microbiology and Immunology | 1998
Paola Goldoni; L. Cattani; Stefania Carrara; Maddalena Castellani Pastoris; L. Sinibaldi; N. Orsi
A study has been carried out on the action of cytoskeleton and metabolic inhibitors on intracellular multiplication in HeLa cells of a virulent strain of Legionella pneumophila serogroup 6. The effects of the substances were separately tested on both penetration and intracellular multiplication of L. pneumophila. Only cytochalasin A and 2‐deoxy‐d‐glucose (2dG) affected bacterial internalisation, whereas intracellular multiplication was inhibited by cytochalasins A, B, C, D and J (D being the most active) and by 2dG with a dose‐response effect. The action of 2dG was counteracted by 50 mM glucose. Experiments carried out with cytochalasin D and a rhodamine‐phalloidin conjugate showed the involvement of cytoskeletal elements in intracellular multiplication of Legionella; compounds acting on microtubules had no effect.
Journal of Clinical Microbiology | 1997
Jürgen H. Helbig; J B Kurtz; Maddalena Castellani Pastoris; C Pelaz; Paul Christian Lück
Clinical Microbiology and Infection | 1999
Norman K. Fry; Stella Alexiou-Daniel; Jette Marie Bangsborg; Sverker Bernander; Maddalena Castellani Pastoris; Jerome Etienne; Benita Forsblom; Valeria Gaia; Jörgen H. Helbig; Diane Lindsay; P. Christian Löck; Carmen Pelaz; Søren A. Uldum; Timothy G. Harrison
Journal of Clinical Microbiology | 1999
Paolo Visca; Paola Goldoni; P. Christian Lück; Jürgen H. Helbig; L. Cattani; Giuseppe Giltri; Simone Bramati; Maddalena Castellani Pastoris
Clinical Infectious Diseases | 1999
Maddalena Castellani Pastoris; Renato Lo Monaco; Paola Goldoni; Bruno Mentore; Giacomo Balestra; Lorenzo Ciceroni
Vaccine | 2005
Maria Luisa Ricci; Antonella Torosantucci; Maria Scaturro; Paola Chiani; Lucilla Baldassarri; Maddalena Castellani Pastoris
Journal of Medical Microbiology | 1991
Paola Goldoni; Paolo Visca; Maddalena Castellani Pastoris; Piera Valenti; N. Orsi